FDx Advisors Inc. trimmed its position in Itron (NASDAQ:ITRI) by 16.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,291 shares of the scientific and technical instruments company’s stock after selling 827 shares during the period. FDx Advisors Inc.’s holdings in Itron were worth $307,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. KBC Group NV increased its position in shares of Itron by 53.9% in the 4th quarter. KBC Group NV now owns 262,572 shares of the scientific and technical instruments company’s stock valued at $17,907,000 after acquiring an additional 91,981 shares during the period. Rockefeller Financial Services Inc. increased its position in shares of Itron by 26.2% in the 4th quarter. Rockefeller Financial Services Inc. now owns 12,230 shares of the scientific and technical instruments company’s stock valued at $834,000 after acquiring an additional 2,536 shares during the period. Smith Graham & Co. Investment Advisors LP increased its position in shares of Itron by 2.0% in the 4th quarter. Smith Graham & Co. Investment Advisors LP now owns 132,597 shares of the scientific and technical instruments company’s stock valued at $9,043,000 after acquiring an additional 2,540 shares during the period. First Trust Advisors LP increased its position in shares of Itron by 14.8% in the 4th quarter. First Trust Advisors LP now owns 228,251 shares of the scientific and technical instruments company’s stock valued at $15,567,000 after acquiring an additional 29,441 shares during the period. Finally, BlueCrest Capital Management Ltd acquired a new position in shares of Itron in the 4th quarter valued at $977,000. 94.50% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ:ITRI opened at $58.15 on Friday. Itron has a one year low of $60.13 and a one year high of $61.55. The company has a debt-to-equity ratio of 1.57, a quick ratio of 1.29 and a current ratio of 1.46. The firm has a market capitalization of $2.34 billion, a price-to-earnings ratio of 19.00, a price-to-earnings-growth ratio of 0.94 and a beta of 1.00.

Itron (NASDAQ:ITRI) last posted its earnings results on Monday, May 14th. The scientific and technical instruments company reported $0.13 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.13. Itron had a negative net margin of 4.85% and a positive return on equity of 13.59%. The business had revenue of $607.00 million for the quarter, compared to analyst estimates of $575.74 million. During the same period in the prior year, the company posted $0.57 EPS. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. sell-side analysts anticipate that Itron will post 3.02 earnings per share for the current year.

In other news, insider Philip Mezey sold 16,694 shares of the stock in a transaction dated Tuesday, May 1st. The shares were sold at an average price of $65.15, for a total transaction of $1,087,614.10. Following the sale, the insider now directly owns 93,341 shares of the company’s stock, valued at approximately $6,081,166.15. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Shannon M. Votava sold 6,661 shares of the stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $71.58, for a total transaction of $476,794.38. Following the sale, the vice president now directly owns 16,459 shares in the company, valued at $1,178,135.22. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,402 shares of company stock worth $2,275,266. Corporate insiders own 2.03% of the company’s stock.

Several equities research analysts have commented on ITRI shares. Canaccord Genuity reaffirmed a “buy” rating and issued a $84.00 price target on shares of Itron in a report on Wednesday, April 4th. Zacks Investment Research raised shares of Itron from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a report on Tuesday, May 1st. Oppenheimer reaffirmed a “buy” rating and issued a $78.00 price target on shares of Itron in a report on Monday, January 29th. BidaskClub raised shares of Itron from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Finally, ValuEngine raised shares of Itron from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating, six have issued a buy rating and two have given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $83.36.

Itron Company Profile

Itron, Inc, a technology company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Electricity, Gas, and Water. It offers standard electromechanical and electronic, gas, and water and heat meters; and smart electricity, gas, and water meters and communication modules.

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron (NASDAQ:ITRI).

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.